Shaping the future of PDAC care: Scientific advances and therapeutic innovation
How is therapeutic innovation shaping the future of care in PDAC? In this expert-led activity, Eileen O’Reilly, Michel Ducreux and Thomas Hope provide a focused review of the evolving treatment landscape for pancreatic ductal adenocarcinoma. They explore: • Unmet needs in current PDAC management • The science and mechanisms behind emerging therapeutics • Practical strategies to support integration of novel treatment approaches into clinical practice Designed for oncology HCPs, this discussion highlights where innovation is heading and what it means for real-world patient care. 🎓 CME credits available 👉 Watch the full activity here: https://touchoncologyime.org/future-p... The activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. #PancreaticCancer #OncologyEducation #CME #CancerCare #MedicalEducation

Targeting brain metastases in advanced NSCLC: The emerging impact of ADCs

Strategic Sequencing: Mapping the Optimal Path for Later-Line mCRC Care

Integrating neurosensory pathway insights into modern dry eye management

RASolute 302 Pancreatic Cancer Study with Daraxonrasib at ASCO 2026 – Dr. Brian Wolpin

Day 2 | Scaling What Matters: Economic Evidence to Inform Policy | #BIOMARKERS26

TypeScript in Express – TypeScript Tutorial

The PROBLEM with Capitalism - Smarter Every Day 316

Things they DON’T talk about out loud. Insights from 20 years of family therapy practice.

How the Moon Becomes the Solar System’s Shipping Yard

Chichvarkin Saves Putin | Vitaly Portnikov

Do THIS and a Narcissist Will Apologize for Hurting You – It Actually Works | DR. RAMANI

🔥ГРОЗЕВ: Путин готовится ЖИТЬ ВЕЧНО? Тайный проект Кремля РАСКРЫТ!

Advancing outcomes in CP-CML: Approaches to treatment decisions, monitoring & toxicity management

The Immunotherapy Casebook: Practical Approaches in Frontline Metastatic NSCLC Treatment

Why does every mammal get 1 billion heartbeats in their life?

Updates & Innovations in ALS Clinical Trial Landscape by Dr. Jinsy Andrews

Evolving Paradigms in PNH Management: Interpreting the Latest Data

Day 1 | The Patient Voice Amplified: CGP Across Tumour Types | #BIOMARKERS26

Update on CAR T-Cell Therapy | Lymphoma Research Foundation Webinars

